WeightWatchers partners with U.K.-based CheqUp to expand GLP-1 support, following news of its Chapter 11 and focus on long-term growth.
ISSA launches a GLP-1 support course to help fitness pros guide clients through weight loss, behavior change and long-term health success.
Zepbound helped patients lose more weight than Wegovy in a 72-week trial, with greater reductions in both body weight and waist size.
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
Echelon has been a fitness industry player since 2017—and now it’s leveling up with ActiveMD, offering customers access to weight loss drugs.
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Anthony Geisler addresses his departure from Xponential and analyzes the current fitness and wellness landscape in an exclusive interview.
GLP-1 drugs are making headlines for their weight-loss powers, but they might also be effective in helping people kick alcohol dependency.
Increasing access to GLP-1 weight-loss drugs can be the ticket to employee productivity and retention, the corporate wellness platform
JP Morgan Private Capital has raised over $500 million for a life sciences fund targeting private biotech companies and the booming weight-loss drug space.
Sign Up to Our Newsletter
